4Xu H,Chen LM,Li XW, et aI.Risk factors and prognosis of contrast induced nephropathy with renal dysfunction[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2005,27(2):232-236.
5Solomon R,Deray G.How to prevent contrast-induced nephropathy and manage risk patients: Practical recommendations[J].Kidney Intemat,2006,69(Suppl 100):S51-S53.
6Briguori C,Airoldi F, Morici N,et al.New pharmacological protocols to prevent or reduce contrast media nephropathy[J]. Minerva Cardioangiol,2005,53(1):49-58.
8Khwannimit B, Bhurayanontachai R. The epidemiology of, and risk factors for mortality from severe sepsis and septic shock in a tertiary care university hospital setting[J]. Epidemiol Infect, 2009,137(9) : 1333-1341.
9Levy MM,Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference [J]. Crit Care Med,2003,31(4):1250-1256.
10Pinsky MR. Sepsis:a pro- and anti-inflammatory disequilibrium syndrome[J]. Contrib Nephroi,2001, (132) : 355-366.
